fbpx
Menu
Articles

Does Topical Dutasteride Work?

First Published Sep 18 2025
Last Updated Sep 19 2025
Pharmaceutical
Researched & Written By:
Sarah King, PhD
Reviewed By:
Rob English, Medical Editor
Does Topical Dutasteride Work?

Article Summary

Topical dutasteride is gaining attention as a potent alternative to oral dutasteride (and finasteride) in treating androgenic alopecia, aiming to deliver robust DHT suppression at the scalp with fewer systemic side effects. But does topical dutasteride work? In this article, we break down how topical dutasteride works, how it compares to the oral version, what formulations and doses show promise, and ways to boost its effectiveness with add-ons like minoxidil or microneedling. Whether you’re considering dutasteride for hair loss or looking to minimize side effect risks, this evidence-based guide will help you weigh the benefits and best practices of going topical.

Full Article

Oral finasteride has long been the mainstay for androgenic alopecia (AGA), but many patients and clinicians have turned to dutasteride, a more potent 5ɑ-reductase inhibitor, in pursuit of superior hair growth. 

Oral dutasteride (0.5 mg daily) can reduce dihydrotestosterone (DHT) by 90% or more (compared to ~70% with finasteride), and clinical studies show it grows more hair than finasteride. In fact, a 24-week trial found that oral dutasteride 0.5 mg significantly outperformed finasteride 1 mg in increasing hair counts.[1]Shanshanwal, S.J.S., Dhurat, R.S. (2017). Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled … Continue reading

However, dutasteride’s very potency raises concerns: will it also increase side effects like decreased libido or hormonal disturbances? Interestingly, research so far suggests that dutasteride has a similar tolerability profile to finasteride with no clear increase in sexual side effects despite its stronger DHT suppression.[2]Almudimeegh, A., Almutairi, H., AlTassan, F., AlQuraishi, Y., Nagshabandi, K.N. (2024). Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and … Continue reading 

Even so, oral dutasteride’s reputation (it’s approved for prostate enlargement and used off-label for hair loss) makes some men uneasy, especially those who experienced side effects on finasteride. This has led to rising interest in topical dutasteride formulations. By delivering dutasteride directly to the scalp, the goal is to concentrate its DHT-blocking action where it’s needed (hair follicles) while limiting how much enters the bloodstream. The questions we need to answer are:

  • Does topical dutasteride work?
  • Does it match or even exceed the efficacy of oral treatments?
  • Can it maintain these benefits with a more favorable side effect profile?

Ulo offers dutasteride options that range from low to high dose dutasteride – allowing you to be flexible in your treatment choices.

Interested in Topical Dutasteride?

Hair gains bigger than finasteride? Dutasteride makes this possible, if prescribed*

Take the next step in your hair regrowth journey. Get started today with a provider who can prescribe a topical solution tailored for you.

Click Here For 15% Off

*Only available in the U.S. Prescriptions not guaranteed. Restrictions apply. Off-label products are not endorsed by the FDA.

Oral vs. Topical Dutasteride

Early evidence indicates that topical dutasteride can indeed improve hair growth, in some cases achieving results comparable to oral therapy but with lower systemic DHT reduction. 

Study One

One study tested dutasteride solutions of 0.01%, 0.02%, and 0.05% against a placebo (and an active control) over 24 weeks. All dutasteride groups showed significant increases in hair count versus placebo, and the 0.05% topical solution actually showed more efficacy than oral finasteride (1 mg/day) in promoting regrowth.[3]Panuganti, V.K., Madala, P.K., Grandhi, V.R., Alluri, C.V., Mohammed, J., Rao, S., Dundigalla, M.R. (2025). A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the … Continue reading

Figure 1: Representative images of hair growth in male-pattern androgenetic alopecia after treatment with 0.01% dutasteride topical solution at 12 week (b) and 24 week (c) vs baseline (a); 0.02% dutasteride topical solution at 12 week (e) and 24 week (f) vs baseline (d); 0.05% dutasteride topical solution at 12 week (h) and 24 week (i) vs baseline (g); oral finasteride 1 mg tablets at week 12 (k) and week 24 (l) vs baseline (j); placebo at week 12 (n) and week 24 (o) vs baseline (m).[4]Panuganti, V.K., Madala, P.K., Grandhi, V.R., Alluri, C.V., Mohammed, J., Rao, S., Dundigalla, M.R. (2025). A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the … Continue reading Image obtained in line with the PMC Copyright License.

Study Two

A recent randomized controlled study compared oral dutasteride (0.5 mg daily) to topical dutasteride (0.02% administered via monthly microneedling), both combined with daily topical minoxidil 5%. The trial found that all groups (including minoxidil alone) saw improvement, but the topical dutasteride via microneedling group demonstrated results comparable to the oral dutasteride group in terms of increased hair density and width, with the added advantage of fewer systemic side effects.[5]Obeid, M.N.A., Fatteh, N.S.A., Elfangary, M.M., Husseni, R.M.A. (2024). Comparison between Topical Minoxidil 5% Alone versus Combined with Dutasteride (Topical 0.02% through Microneedling or Oral 0.5 … Continue reading  

Patient satisfaction and physician assessment favored the microneedling + topical dutasteride group, suggesting that this method may offer similar efficacy to systemic dutasteride, but with reduced risk of systemic adverse effects. The study included both men and women with AGA.

How Does Dutasteride Work?

Dutasteride is a potent inhibitor of the enzyme 5ɑ-reductase, which exists in multiple isoforms in the body. Unlike finasteride (which selectively targets the type II isoenzyme), dutasteride blocks both type I and type II 5ɑ-reductase.[6]Botto, H., Lan, O., Poulain, J-E., Comenducci, A. (2005). Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia. Progrés en … Continue reading 

Type II is abundant in hair follicles and the prostate, while Type I is found in skin, sebaceous glands, and liver. By inhibiting both, dutasteride more completely prevents the conversion of testosterone to DHT.

At a standard oral dose of 0.5 mg/day, dutasteride can drive serum and scalp DHT levels down by ~90% or more.[7]Ding, Y., Wang, C., Bi, L., Du, Y., Lu, C., Zhao, M., Fan, W. (2024). Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. Dermatology. (5-6). 833-843. Available at: … Continue reading This is a more extensive suppression than finasteride achieves at typical doses. This dramatic drop in DHT removes the androgenic stimulus that causes susceptible hair follicles to shrink and enter shorter growth phases, thereby slowing hair loss and allowing follicles to recover over time. 

Topical dutasteride aims to harness this same mechanism locally. When applied on the scalp, dutasteride penetrates into the skin and hair follicle, binding to 5ɑ-reductase enzymes in the dermis and around the follicle bulb. Inhibiting local DHT production creates a scalp environment more conducive to hair growth. 

Pharmacokinetic studies of dutasteride demonstrate parallel linear and nonlinear elimination, with nonlinear (saturable) pathways dominating at low doses. These pathways quickly become saturated, so even small concentrations can lead to substantial enzyme inhibition. As drug concentrations rise and saturate the target enzyme, higher doses yield diminishing increases in effect.[8]Gisleskog, P.O., Hermann, D., Hammarlund-Udenaes, M., Karlsson, M.O. (1999). The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination. … Continue reading

Therefore, topical dutasteride at 0.01-0.05% may achieve a large fraction of the DHT reduction that an oral dose would, as long as it reaches the target tissue. This is why even leakage of a small dose into circulation can suppress serum DHT measurably.

Another factor is dutasteride’s long half-life, about 4-5 weeks.[9]Azzouni, F., Godoy, A., Li, Y., Mohler, J. (2011). The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases. Advances in Urology. 2012(530121). 1-18. Available … Continue reading This prolonged half-life means that any dutasteride absorbed systemically will accumulate with continued use. From a mechanism standpoint, this is a double-edged sword: 

  • It ensures continuous enzyme inhibition (dutasteride remains bound to 5ɑ-reductase).
  • But it also means systemic exposure is amplified over time if absorption isn’t minimized. 

What the Science Says

Research on topical dutasteride is not as extensive as that on topical finasteride, but a growing number of trials and case series shed light on its efficacy. Below, we summarize key findings across different concentrations and use cases:

Study Concentration & Vehicle Hair Growth-Outcomes Systemic/Serum Findings
Nada et al, 2018, prospective randomized study, 30 men, 24 weeks. Group 1: Minoxidil + topical dutasteride (0.02%).

Group 2: Minoxidil only.

Group 1 showed a significant increase in hair density, width, and terminal/vellus ratio compared to Group 2. Patient assessment showed higher satisfaction in Group 1 than in Group 2. Reduction in serum DHT observed.
Sanchez-Meta et al, 2022, double-blind RCT, 34 men, 16 weeks. Group 1: Minoxidil and topical dutasteride (0.01%).

Group 2: Minoxidil only.

Minoxidil and dutasteride produced a superior overall change in hair thickness and density compared to minoxidil alone. Not evaluated.
Panuganti et al, 2025, phase II randomized, double-blind study, 135 men, 24 weeks. Group 1: Dutasteride 0.01% w/v topical solution. Group 2: Dutasteride 0.02% w/v. Group 3: Dutasteride 0.05% w/v. Group 4: Oral finasteride 1 mg. Group 5: Placebo. Dose-dependent increase in target area hair count (TAHC) vs placebo. Dutasteride 0.05% superior to finasteride at week 24. Mean TAHC increase: 0.01% (12.78), 0.02% (20.03), 0.05% (34.30) vs finasteride (12.57). More patients achieved investigator global photography assessment ≥+2 with 0.05% vs finasteride. Dutasteride caused modest changes in serum testosterone/DHT, while finasteride caused moderate changes. 0.05% dutasteride showed a better pharmacokinetic profile with reduced systemic absorption compared to oral finasteride.

Overall, while there is a lack of peer-reviewed scientific literature, it does support the idea that topical dutasteride is an effective treatment for AGA. Where topical dutasteride does shine is in offering these benefits with reduced systemic involvement, making it a potential option for those who need dutasteride’s effects but are wary of its systemic effects.

Why Formulation and Dose Matter

Not all topical dutasteride products are created equal. Two main factors determine how well topical dutasteride works (and how “safe” it is systemically): formulation (the vehicle and additives) and dosage regimen (concentration and frequency).

  • Vehicle and Penetration: Dutasteride is a large lipophilic molecule with poor water solubility.[10]Kim, N.A., Choi, D.H., Kim, J.Y., Kim, K.H., Lim, D.G., Lee, E., Park, E-S., Jeong, S.H. (2014). Investigation of polymeric excipients for dutasteride solid dispersion and its physicochemical … Continue reading This makes formulation challenging; you need solvents or carriers that keep it stable and help it traverse the skin barrier. Newer vehicles like lipid carriers or cyclodextrin inclusion complexes might improve scalp targeting while limiting diffusion into blood.[11]Kim, M-S., Ha, E-S., Choo, G-H., Baek, I-H. (2015). Preparation and in vivo evaluation of a dutasteride-loaded solid-supersaturable self-microemulsifying drug delivery system. International Journal … Continue reading,[12]Min, M-H., Park, J-H., Choi, M-R., Hur, J-H., Ahn, B-N., Kim, D-D. (2018). Formulation of a film-coated dutasteride tablet bioequivalent to a soft gelatin capsule (Avodart): Effect of γ-cyclodextrin … Continue reading 
  • Applied Dose vs. Concentration: Users often focus on the percentage (e.g., 0.1% vs 0.02%), but the total amount of drug applied per session is just as important. For example, using 2 mL of a 0.1% solution (which contains 2 mg dutasteride) will deliver four times the dutasteride to your scalp as 1 mL of the same solution. For example, one study using a 0.25% topical used at 4 sprays (around 400 μL) caused a much larger drop in serum DHT than the same solution used at 1-2 sprays (100-200 μL).[13]Ding, Y., Wang, C., Bi, L., Du, Y., Lu, C., Zhao, M., Fan, W. (2024). Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. Dermatology. 240(5-6). 833-843. Available at: … Continue reading 
      • Furthermore, volume matters: a seemingly “low” concentration could cause systemic effects if applied in large quantities. Conversely, high concentrations used sparingly might localize better. 
  • Dosing Frequency: Dutasteride’s long half-life means you may not need daily application to maintain its effect on the scalp. Ultimately, the goal is to find a regimen that keeps follicles saturated with dutasteride whilst avoiding leakage into the bloodstream.

Minimizing Systemic Absorption

As we have mentioned above, one of the primary motivations for using topical dutasteride is to limit the risk of side effects that come with systemic DHT suppression. There are several strategies you can use to achieve this. 

Vehicle & Penetration Enhancers

As discussed, formulation plays a huge role. Nanoemulsion-based gels and nanoemulgels significantly increase skin permeation and deposition of dutasteride compared to conventional formulations, with optimized nanoemulsions showing up to 1.5-fold enhancement in permeation.[14]Ali, M.S., Alam, M.S., Alam, N., Siddiqui, M.R. (2014). Preparation, Characterization and Stability Study of Dutasteride-Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy. Iranian … Continue reading If systemic absorption is a concern, you could opt for a slightly less efficient formulation. 

Time On Scalp

The longer the product stays on your scalp, the more the drug can penetrate, increasing efficacy (and potentially systemic absorption). Washing your hair too soon can rinse away some of the medication, potentially reducing efficacy. Many protocols recommend allowing at least 4 hours of contact time (and preferably 6-8 hours) before washing off a topical. 

Application Frequency

Frequency can be adjusted to manage systemic load. Because dutasteride binds 5ɑ-reductase for so long, daily application might not be necessary for full benefit. If you find that daily use lowers your serum DHT more than desired, you could try every other day or even twice-weekly dosing. 

Scalp Condition and Individual Variation

Your skin’s permeability is unique to you..Differences in skin thickness can affect drug permeability (and therefore efficacy).[15]Noor, N.M., Abudl-Aziz, A., Sheikh, K., Somavarapu, S., Taylor, K.M.G. (2020). In vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal … Continue reading However, you should be mindful that if you have a scalp condition (like seborrheic dermatitis, etc), you should avoid using any topical hair loss treatments until it has resolved.

Application Area

The larger the area of scalp you treat, the more drug can be absorbed. Treating just the crown vs. the entire scalp could proportionally change systemic exposure. If you have diffuse thinning and apply broadly, you might consider using a lower concentration to compensate for the larger area.

To minimize systemic absorption without compromising results, a practical approach can be:

  • Use the lowest effective concentration.
  • Use the smallest effective volume.
  • Use the least frequent schedule.

This will often require trial and error as you find out what works for you. If you notice side effects like decreased libido, brain fog, or breast tenderness, these could be signs of systemic absorption. In such cases, dial back the frequency or concentration.

How to Maximize Gains and Minimize Risk

If you decide to use topical dutasteride, here are strategies to get the best hair growth results while keeping your risk low:

  • Establish a Baseline (Lab Tests): Before starting, it’s wise to get bloodwork for your hormone levels – especially serum DHT and testosterone. This baseline will tell you where you started. Some people also get a full hormone panel (if advised to do so by their doctor). You can then re-test after 4-6 weeks to monitor any significant changes.
  • Standardize Your Application Routine: Consistency is key for results. Apply the treatment to a dry scalp. If using a dropper or spray, try to target thinning areas evenly and rub it in gently. Pick a time of day you can stick with. Many prefer nighttime so it can absorb overnight; just be cautious about transferring to pillows (and thereby to partners). If you apply it in the morning, ensure it dries before any activity that might cause sweat (sweating could increase absorption or cause the product). 
  • Add Proven Adjuncts (like minoxidil or microneedling): To maximize regrowth, consider combining therapies. Minoxidil can synergize with dutasteride by stimulating follicles directly, while dutasteride tackles the hormonal aspect. As seen above, studies show that dutasteride and minoxidil yield better density than either alone. Microneedling is another option. Weekly or monthly sessions of dermarolling have been shown to boost topical drug delivery and induce growth factors.[16]Ahmed, K.M.A., Kozaa, Y.A., Abuawwad, M.T., Al-Najdawi, A.I., Mahmoud, Y.W., Ahmed, A.M., Taha, M.J.J., Fadhli, T., Giannopoulou, A. (2025). Evaluating the efficacy and safety of combined … Continue reading 
  • Be Patient and Track Progress: Hair growth is a slow process. Do not expect major changes in the first weeks. In fact, you might experience some shedding initially. This can happen with any effective treatment and usually subsides. Give the treatment at least 6 months to a year to judge its effect. To accurately gauge progress, use objective tracking, such as standardized photos, hair counting, or a dermascope. 
  • Lifestyle and Supplements: While on treatment, avoid introducing supplements that might complicate treatment. For instance, creatine may increase DHT, and quercetin may decrease it.[17]van der Merwe, J., Brooke, N.E., Myburgh, K.H. (2009). Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players. Clinical … Continue reading,[18]Ma, Z., Nguyen, T.H., Huynh, T.H., Do, P.T., Huynh, H. (2004). Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation. Journal of … Continue reading 
  • Monitor Side Effects: If you notice any difference, then keep a note and let your healthcare provider know. You may be able to adjust the dosage to maintain hair gains and reduce side effects.

Combination Therapies: Enhancing Outcomes

Combination therapy can amplify the benefits of topical dutasteride. We’ve summarized a few of these below:

Dutasteride and Fractional CO2 Laser

One study was conducted in which 30 male AGA patients were randomized to either fractional CO2  laser plus topical dutasteride (0.002%) applied after each session.[19]Galal, S.A., Ali, M.S., HafizHala, H.S.A. (2025). Comparative study between fractional CO2 laser alone versus fractional CO2 laser combined with topical dutasteride in treatment of male androgenic … Continue reading Each group received 3 sessions, one month apart. The combination group had significantly superior increases in terminal hair count and reductions in vellus hair and hair diameter diversity versus laser alone. Higher patient satisfaction was also reported in the combination group.

Figure 1: Combination treatment results: (A) Clinical photos before treatment (B) showing moderate improvement after treatment. (C) dermoscopic photos before treatment, counting vellus hair (16.8%), terminal hair (83.2%), and calculating hair diameter diversity (52.1%) per field. (D) dermoscopy after treatment with fractional CO2 laser combined with topical dutasteride; vellus hair (13.5%), terminal hair (86.5%), and hair diameter diversity (86.5%) per field. Vellus hair; blue arrow, terminal hair; black arrow, single pilosebaceous unit; green arrow, and yellow dot; yellow arrow.[20]Galal, S.A., Ali, M.S., HafizHala, H.S.A. (2025). Comparative study between fractional CO2 laser alone versus fractional CO2 laser combined with topical dutasteride in  treatment of male androgenic … Continue reading Image obtained in line with the Creative Commons License.

Triple Topical Therapy: Dutasteride, Finasteride, and Minoxidil

Fifteen male AGA patients, including both atopic and non-atopic subjects, used a topical compound containing finasteride, dutasteride, and minoxidil (“NuH Hair”), with optional additions of oral finasteride, topical minoxidil foam, and ketoconazole shampoo.[21]Rafi, A.W., Katz, R.M. (2011). Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA. ISRN Dermatology. 2011(241953). Available at: … Continue reading

All patients experienced significant new hair growth. Among those using all four components, significant regrowth was seen as early as 30 days, with “major” growth in three patients by day 30 and in all by day 60.  In those using only the triple topical, significant regrowth was observed in all by 3 months, despite some using it less frequently than recommended.  No systemic or local adverse effects were reported.

Topical Dutasteride + Microneedling

A 20-week, randomized, double-blind, placebo-controlled trial of microneedling plus topical 0.01% dutasteride solution (MNSD) vs. microneedling plus saline. The combination group demonstrated significant improvement in hair growth and density compared to the control. No systemic androgen suppression was detected, indicating a favorable safety profile.[22]Sanchez-Meza, E., Ocampo-Candiani, J., Gomez-Flores, M., Herz-Ruelas, M.E., Ocampo-Garza, J., Orizaga-y-Quiroga, T.L., Martinez-Moreno, A., Ocampo-Garza, S.S. (2022). Microneedling plus topical … Continue reading 

The overarching theme of combinations like the above is synergy. By attacking hair loss from multiple angles, you often get faster, fuller, and more sustained regrowth.

Who Should (or Shouldn’t) Use Topical Dutasteride

Good Candidates

  • Men with AGA who need a stronger option.
  • Those who experienced side effects from oral finasteride/dutasteride.

Bad Candidates

  • Anyone trying to conceive, or with infants, toddlers, or pregnant partners.
  • People with non-AGA hair loss.
  • Those with severe persistent side effects from 5ɑ-reductase inhibitors.
  • People who aren’t able to commit to a consistent routine.

Final Verdict

So, does topical dutasteride work? In short, yes. Clinical trials and real-world use show that topical dutasteride can significantly improve hair growth and reduce shedding in men with androgenetic alopecia. When formulated correctly, it offers comparable scalp DHT suppression and regrowth potential to oral finasteride, and in some cases, it even approaches the efficacy of oral dutasteride, but with lower systemic exposure and fewer side effects.

The key is proper use. Results depend heavily on the right concentration, vehicle, dosage, and frequency. A well-balanced regimen, often guided by a medical provider, offers the best chance of success.

References

References
1 Shanshanwal, S.J.S., Dhurat, R.S. (2017). Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. 83(1). 47-54. Available at: https://doi.org/10.4103/0378-6323.188652
2 Almudimeegh, A., Almutairi, H., AlTassan, F., AlQuraishi, Y., Nagshabandi, K.N. (2024). Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review. Dermatology Reports. 16(4). 9909. Available at: https://doi.org/10.4081/dr.2024.9909
3 Panuganti, V.K., Madala, P.K., Grandhi, V.R., Alluri, C.V., Mohammed, J., Rao, S., Dundigalla, M.R. (2025). A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects with Androgenetic Alopecia. Cureus. 17(8). E89309. Available at: https://doi.org/10.7759/cureus.89309
4 Panuganti, V.K., Madala, P.K., Grandhi, V.R., Alluri, C.V., Mohammed, J., Rao, S., Dundigalla, M.R. (2025). A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects with Androgenetic Alopecia. Cureus. 17(8). E89309. Available at: https://doi.org/10.7759/cureus.89309
5 Obeid, M.N.A., Fatteh, N.S.A., Elfangary, M.M., Husseni, R.M.A. (2024). Comparison between Topical Minoxidil 5% Alone versus Combined with Dutasteride (Topical 0.02% through Microneedling or Oral 0.5 mg) in Treatment of Androgenetic Alopecia. An International Journal of Medicine. 117(2). Available at: https://doi.org/10.1093/qjmed/hcae175.207
6 Botto, H., Lan, O., Poulain, J-E., Comenducci, A. (2005). Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia. Progrés en Urologie. 15(6). 1090-1095. Available at: PMID: 16429658
7 Ding, Y., Wang, C., Bi, L., Du, Y., Lu, C., Zhao, M., Fan, W. (2024). Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. Dermatology. (5-6). 833-843. Available at: https://doi.org/10.1159/000541395
8 Gisleskog, P.O., Hermann, D., Hammarlund-Udenaes, M., Karlsson, M.O. (1999). The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination. British Journal of Clinical Pharmacology. 47(1). 53-58. Available at: https://doi.org/10.1046/j.1365-2125.1999.00843.x
9 Azzouni, F., Godoy, A., Li, Y., Mohler, J. (2011). The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases. Advances in Urology. 2012(530121). 1-18. Available at: https://doi.org/10.1155/2012/530121
10 Kim, N.A., Choi, D.H., Kim, J.Y., Kim, K.H., Lim, D.G., Lee, E., Park, E-S., Jeong, S.H. (2014). Investigation of polymeric excipients for dutasteride solid dispersion and its physicochemical characterization. Archives of Pharmacal Research. 37(2). 214-224. Available at: https://doi.org/10.1007/s12272-013-0180-9
11 Kim, M-S., Ha, E-S., Choo, G-H., Baek, I-H. (2015). Preparation and in vivo evaluation of a dutasteride-loaded solid-supersaturable self-microemulsifying drug delivery system. International Journal of Molecular Sciences. 16(5). 10821-10833. Available at: https://doi.org/10.3390/ijms160510821
12 Min, M-H., Park, J-H., Choi, M-R., Hur, J-H., Ahn, B-N., Kim, D-D. (2018). Formulation of a film-coated dutasteride tablet bioequivalent to a soft gelatin capsule (Avodart): Effect of γ-cyclodextrin and solubilizers. Asian Journal of Pharmaceutical Sciences. 14(3). 313-320. Available at: https://doi.org/10.1016/j.alps.2018.08.007
13 Ding, Y., Wang, C., Bi, L., Du, Y., Lu, C., Zhao, M., Fan, W. (2024). Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. Dermatology. 240(5-6). 833-843. Available at: https://doi.org/10.1159/000541395
14 Ali, M.S., Alam, M.S., Alam, N., Siddiqui, M.R. (2014). Preparation, Characterization and Stability Study of Dutasteride-Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy. Iranian Journal of Pharmaceutical Research. 13(4). 1125-1140. Available at: PMID: 25587300
15 Noor, N.M., Abudl-Aziz, A., Sheikh, K., Somavarapu, S., Taylor, K.M.G. (2020). In vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery. Pharmaceutics. 12(10). 994. Available at: https://doi.org/10.3390/pharmaceutics12100994
16 Ahmed, K.M.A., Kozaa, Y.A., Abuawwad, M.T., Al-Najdawi, A.I., Mahmoud, Y.W., Ahmed, A.M., Taha, M.J.J., Fadhli, T., Giannopoulou, A. (2025). Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis. Archives of Dermatological Research. 317(1). 528. Available at: https://doi.org/10.1007/s00403-025-04032-1
17 van der Merwe, J., Brooke, N.E., Myburgh, K.H. (2009). Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players. Clinical Journal of Sports Medicine. 19(5). 399-404. Available at: https://doi.org/10.1097/JSM.0b013e3181b8b52f.
18 Ma, Z., Nguyen, T.H., Huynh, T.H., Do, P.T., Huynh, H. (2004). Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation. Journal of Endocrinology. 181(3). 493-507. Available at: https://doi.org/10.1677/joe.0.1810493
19 Galal, S.A., Ali, M.S., HafizHala, H.S.A. (2025). Comparative study between fractional CO2 laser alone versus fractional CO2 laser combined with topical dutasteride in treatment of male androgenic alopecia. 40(1). 16. Available at: https://doi.org/10.1007/s10103-024-04269-8
20 Galal, S.A., Ali, M.S., HafizHala, H.S.A. (2025). Comparative study between fractional CO2 laser alone versus fractional CO2 laser combined with topical dutasteride in  treatment of male androgenic alopecia. 40(1). 16. Available at: https://doi.org/10.1007/s10103-024-04269-8
21 Rafi, A.W., Katz, R.M. (2011). Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA. ISRN Dermatology. 2011(241953). Available at: https://doi.org/10.5402/2011/241953
22 Sanchez-Meza, E., Ocampo-Candiani, J., Gomez-Flores, M., Herz-Ruelas, M.E., Ocampo-Garza, J., Orizaga-y-Quiroga, T.L., Martinez-Moreno, A., Ocampo-Garza, S.S. (2022). Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study. JEADV. 36(10). Available at: https://doi.org/10.1111/jdv.18285
Sarah King, PhD

Sarah King, PhD

Dr. Sarah King is a researcher & writer who holds a BSc in Medical Biology, an MSc in Forensic Biology, and a Ph.D. in Molecular and Cellular Biology. While at university, Dr. King’s research focused on cellular aging and senescence through NAD-dependent signaling – along with research into prostaglandins and their role in hair loss. She is a co-author on several upcoming manuscripts with the Perfect Hair Health team.

"... Can’t thank @Rob (PHH) and @sanderson17 enough for allowing me to understand a bit what was going on with me and why all these [things were] happening ... "
photo photo
— RDB, 35, New York, U.S.A.
"... There is a lot improvement that I am seeing and my scalp feel alive nowadays... Thanks everyone. "
photo photo
— Aayush, 20’s, Boston, MA
"... I can say that my hair volume/thickness is about 30% more than it was when I first started."
photo photo
— Douglas, 50’s, Montréal, Canada